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BACKGROUND: The thyroidal lymphoid infiltrate (TLI) in Hashimoto thyroiditis (HT) represents the sub-
strate from which thyroid lymphoma may arise. The objective of the current study was to classify the TLI in
HT by comparing the cytologic features with flow cytometry (FC) data and evaluating the j/k light chain
ratio and its molecular assessment. METHODS: Fine-needle aspiration cytology (FNAC) was performed in
34 patients with HT with nodular or diffuse palpable enlargement of the gland. Two or 3 passes were per-
formed to prepare traditional smears, FC, and immunophenotyping, and RNAlater suspensions for molecu-
lar assessment. FC was performed using the following antibodies: CD3, CD5, CD4, CD8, CD10, CD19, and j
and k light chains. In 4 cases, high molecular weight DNA was extracted and used for polymerase chain
reaction (PCR) to amplify the variable diversity joining region of the heavy chain immunoglobulin (Ig)
genes (IgH). Statistical analysis was performed to evaluate possible associations between clinical ultra-
sound presentation, cytologic pattern, and TLI phenotype. Light chain expression was evaluated as the per-
centage of the expressing cells (20% and >20%) and as the j/k ratio. RESULTS: Smears were classified as
‘‘lymphocytic,’’ ‘‘lymph node-like,’’ or ‘‘mixed.’’ FC demonstrated T cells (CD3 positive [þ], CD5þ) in all cases,
and T cells and B cell (CD19þ, CD10þ/-) lymphocytes in 22 cases. Light chains were expressed in 30 cases
(in <20% of the gated cells in 13 cases and in >20% of the gated cells in 17 cases). Five cases demon-
strated small j/k ratio imbalances and PCR analysis demonstrated diffuse bands in the gel and Gaussian
curves at the heteroduplex. Statistical analysis indicated significant associations between the ‘‘lymphocytic’’
pattern and T-cell phenotype and between the ‘‘lymph node-like’’ pattern and B-cell phenotype. A signifi-
cant association also was observed between light chain restriction and low light chain expression (P <
.005). CONCLUSIONS: The cytologic pattern of TLI in HT is quite representative of the clinical presentation
and phenotypic cell type. Small light chain imbalances are not sustained by heavy chain Ig gene (IgH) rear-
rangements. FNA coupled with FC may contribute to making the distinction between florid TLI and non-
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Hashimoto thyroiditis (HT) is the most frequent
chronic autoimmune disease diagnosed in the Western
world and develops as a result of the interaction between
predisposing genetic factors and environmental triggers.1-5
HT is characterized by the progressive loss of follicular
cells and concomitant replacement of the thyroid by a
lymphoid infiltrate (TLI) with the formation of germinal
centers and fibrosis.1,2 The glandmay progressively shrink
until completely atrophic, but in some patients or in some
phases of the disease, there is symmetrical or asymmetrical
enlargement of the gland with the formation of nodules.
HT is also characterized by the presence of antiperoxidase
and antithyroglobulin autoantibodies; an increase in
serum thyroid-stimulating hormone (TSH) may herald
incipient hypothyroidism. Other complications of HT
are papillary carcinoma6,7 and, rarely, non-Hodgkin lym-
phoma (NHL),8 with mucosa-associated lymphoid tissue
(MALT) lymphoma and diffuse large B-cell lymphoma
(DLBCL) being the most frequently reported subtypes.9
Fine-needle aspiration cytology (FNAC) is widely used in
the diagnosis of thyroid nodules, including cases of HT
with diffuse or nodular enlargement. Cytologic criteria
for the diagnosis of HT are well-known,10,11 as are the
problems related to making the distinction between HT
and thyroid lymphoma,12 but to our knowledge relatively
few studies to date have dealt with the cytologic and phe-
notypical characteristics of TLI.13-15 Flow cytometry
(FC) analysis applied to FNAC is a powerful tool in the
study of hematologic neoplasms and j/k light chain
assessment is an important criterion for discriminating
between polyclonal reactive processes and monoclonal
lymphomas.16,17 Some studies performed on TLI using
FC have revealed the existence of a j/k imbalance in HT
lymphoid cells in a variable percentage of cases, without
clinical evidence of NHL.18,19 Moreover, a recent study
using polymerase chain reaction (PCR) to amplify the
variable diversity joining region (VDJ) of the heavy chain
immunoglobulin (Ig) genes (IgH) has reported the pres-
ence of clonal bands in several HT cases without evidence
of thyroid lymphoma during follow-up.20 The objective
of the current study was to classify the TLI in HT and
compare the cytologic features with FC data, with a focus
on the j/k light chain ratio and its molecular assessment.
MATERIALS AND METHODS
Patients
Between January 2005 and December 2007, 1456
patients with palpable thyroid nodules or diffuse swelling
were admitted to the outpatient clinic of the Department
of Pathology and Cytopathology for FNAC. Of these, 64
consecutive patients were diagnosed with or suspected to
have HT because of the clinical, serologic, and/or ultra-
sound (US) presentation. Clinical signs and symptoms
included a swollen thyroid gland with or without discrete
nodules and, more rarely, mild fever. US examination had
been previously performed or was available at the time of
the final diagnosis of HT; the thyroid generally demon-
strated poorly defined hypoechoic areas that occasionally
were permeated by thin fibrous strands with a diffuse
hypervascular pattern or diffuse glandular enlargement
with scattered micronodules and a more hypoechoic echo-
texture than noted in normal thyroid parenchyma.
Thirty-four patients for whom a sufficient amount
of cells could be collected to prepare the smear and to per-
form FC were enrolled in the current study. All the
patients (all of whom were women ages 27-73 years) dem-
onstrated palpable enlargement of the thyroid, had not
received any previous pharmacologic treatment for thy-
roid pathologies, and presented with a US pattern that
was consistent with HT. In fact, at US examination, the
thyroid generally demonstrated the features reported ear-
lier; moreover, in 28 of the selected cases, a discrete and
palpable nodule with the same US features was found to
be present. As a result, the US pattern was classified as
nodular in 28 cases and diffuse in 6.
Serologic assessment was performed in all cases. The
median values were as follows: TSH: 2.8 U/L (range, 0.9-
16.1 U/L); free triiodothyronine (FT3): 3.4 pg/mL
(range, 2.9-4.0 pg/mL); free thyroxine (FT4): 12.1 pg/
mL (range, 8.0-14.3 pg/mL); thyroglobulin antibodies
Lymphoid Infiltrate in Hashimoto Thyroiditis/Zeppa et al
Cancer Cytopathology June 25, 2009 175
(Tg-AB): 212 U/L (range, 86-1240 U/L); and thyroid
peroxidase antibodies (TPO-AB): 89 (range, 48-612 U/
L). Finally, FNAC confirmed the diagnosis of HT in all
cases using the cytologic criteria reported below.
Although none of the patients were clinically sus-
pected of having HT with lymphoma at the time of
enrollment, they underwent special follow-up that
included clinical, US, and serologic examinations per-
formed every 6 months to evaluate clinical features, the
size of the nodular areas and of the whole gland, and func-
tional status. At the time of this report, this follow-up had
been in progress for 11 to 35 months and no complica-
tions, including thyroid lymphoma, had been reported in
any patients.
FNAC
The diagnostic procedure and its related risks were first
discussed with the patients, who were also informed that
1 or 2 supplementary FNAC specimens would be per-
formed, before informed consent was obtained. FNAC
was performed using palpation as previously described7;
in the 2 or 3 passes that were performed, the needle was
moved quickly back and forth in different directions,
thereby ensuring that different areas of the swelling or
nodule were sampled. In all cases, the first FNAC was
used to prepare a traditional smear that was immediately
stained with Diff-Quik and evaluated for adequacy; in the
case of scanty cellularity, the procedure was immediately
repeated. After the smear, the needle was washed
with phosphate-buffered saline (PBS) solution and the
contents carefully flushed out into in a tube; a second
FNAC was then performed and the sample was flushed
out with the same PBS solution and used for FC. In
cases in which the smears were highly cellular with a
large number of lymphocytes and follicular center cells, a
third FNAC was performed and the sample flushed out
with an RNA stabilization solution (RNAlater RNA stabi-
lization reagent; QIAGEN, Hilden, Germany) and stored
at20C.
Cytologic Classification
In keeping with the main cytologic criteria,10,11 the diag-
nosis of HT was made on the basis of a lymphocytic infil-
trate comprised of small lymphocytes, which were either
isolated or intermingled with histiocytes, plasma cells,
stretched lymphocytes, and germinal center lymphoid
cells (eg, transforming lymphocytes, occasional centro-
blasts, and immunoblasts). Follicular cells and Hurthle
cells were present in variable numbers; multinucleated
giant cells were also present on occasion. All the cytologic
diagnoses were confirmed by clinical, serologic, and US
controls. All the smears were subsequently reviewed by 2
of the authors (P.Z. and I.C.), with a focus on the cyto-
logic features of the TLI to quantify the different lymph-
oid components of the smears and classify the TLI
accordingly. Two main cytologic patterns were recog-
nized. In the first, the TLI was mainly comprised of small
lymphocytes that were either isolated or intermingled
with histiocytes, occasional plasma cells, and stretched
lymphocytes. We therefore referred to this pattern as
‘‘lymphocytic’’ (Fig. 1). In the second cytologic pattern, a
second cell population was observed in addition to that of
small lymphocytes and plasma cells. This was comprised
of larger lymphocytes and germinal center lymphoid cells
that gave the smear a lymph node appearance; therefore,
we called it a ‘‘lymph node-like’’ pattern (Fig. 2). Those
smears that demonstrated both cytologic patterns were
termed ‘‘mixed.’’ Blind revision resulted in complete
agreement and therefore all of the cases were reclassified as
lymphocytic, lymph node-like, or mixed on the basis of
their cytologic pattern.
FIGURE 1. Cytologic features of the ‘‘lymphocytic’’ pattern of
Hashimoto thyroiditis, in which small lymphocytes and occa-
sional plasma cells are interspersed in the background. Note
a group of Hurthle cells on the left and a lymphoid tangle on
the right (arrow) (Diff-Quik, 430).
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Flow Cytometry
FC smears were processed within 2 hours, washing twice
by centrifugation for 4 minutes at 2500 revolutions per
minute (rpm), removing the supernatant fluid, and add-
ing 400 lL of PBS. The final suspension was divided
between 3 or 4 tubes and incubated with the following
combination of phycoerythrin (PE), perdin chlorophyll
protein (PERCP), and fluorescein isothiocyanate (FITC)
antibodies: CD3, CD4, CD8, CD5, CD10, CD19, and
j and k light chains. Samples were then incubated for
15 minutes in the dark with 10 lL of antibody and, in the
case of j and k light chains, in permeabilizing solution for
30 minutes in the dark at 4C. All antibodies were pur-
chased from BD Biosciences (San Jose, Calif). After incu-
bation, red blood cells were lysed with ammonium
chloride lysing solution (diluted to 10%) for 5 minutes
followed by washing. When small fragments were still
present, the suspension was filtered through 50-lm filters.
Finally, an equal part of 1% paraformaldehyde was added
to each tube for cell fixation. FC was then performed
using a 3-color analysis technique on a Becton-Dickinson
(San Jose, Calif FACS scan as previously described.15 A
gate of 5000 cells was considered sufficient for phenotyp-
ization and the expression of each antibody was quantified
as a percentage of the whole gate. Light chain expression
was calculated in each case by adding the percentage of j
and k light chain expression and was evaluated as a per-
centage of the whole gate. We then classified each case as
either having low light chain expression when the amount
of expressing cells was <20% of the whole gate (20%)
or as having high light chain expression when the amount
of expressing cells was >20% of the whole gate (>20%).
With regard to the j/k ratio, the nonlymphomatous poly-
clonal range is generally between 0.5 and 3.0,16,17 whereas
exceptional cases of reactive lymph nodes with j/k ratios
as high as 7.0 have been reported.21 Recently, a j/k ratio
of >3.7 in reactive lymph nodes was reported22 and
imbalances of even >3.07 have been described in HT
cases without evidence of thyroid lymphoma.18,19 There-
fore, we considered j/k ratios>4.0 to be imbalanced.
IgH, PCR, and Denaturing
High-performance Liquid
Chromatography Analyses
DNA extraction
In 4 of the 6 processed cases, sufficient high molecu-
lar weight DNA was extracted from the cells obtained by
FNAC and stored in RNAlater using a commercially
available kit (QIAamp DNA Mini Kit; QIAGEN)
according to the manufacturer’s instructions. Samples
were centrifuged at 1300 rpm for 20 minutes to expel the
RNAlater. After discharge of the supernatant fluid, 20 lL
of proteinase K were added to each sample and incubation
at 50C for 3 hours was performed. After a second incuba-
tion at 70C for 10 minutes in 200 lL of buffer AL (QIA-
GEN), 200 lL of ethanol (range, 96-100%) were added
and the mixture was loaded onto a QIAamp Spin Column
(QIAGEN) and centrifuged at 8000 rpm for 1 minute.
The column was then washed with 500 lL of l buffer
AW1 (QIAGEN) by centrifuging at 8000 rpm for 1
minute and 500 lL of l buffer AW2 (QIAGEN) by cen-
trifuging at 14,000 rpm for 3 minutes. When all the resid-
ual ethanol had been removed, DNA was eluted with
70 mL of buffer AE (QIAGEN) by centrifuging at
8000 rpm for 1 minute.
IgH PCR
Using commercially available kits (B lymphomas;
Nanogen, San Diego, Calif) according to the manufac-
turer’s instructions, 2 PCR analyses were performed on
the 4 HT cases plus 4 controls to amplify the VDJ region
of the heavy chain Ig genes (IgH). Two of the 4 controls
FIGURE 2. Cytologic features of the ‘‘lymph nodelike’’ pattern
of Hashimoto thyroiditis. The smear demonstrates mainly
small lymphocytes and a follicular center cell in different
stages of maturation. A follicle structure of thyrocytes is
present in the bottom of the figure (arrow) (Diff-Quik, 430).
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were included in the kit (1 positive and 1 negative) and
2 proven lymphomas from our files were also used. This
method uses a seminested PCR approach to increase the
specificity and sensitivity of the reactions. In the first
round, consensus primer FR2A, homologous to the
framework 2 region of the variable heavy chain region,
and consensus primer LJH, for joining the high chain
region, were used. The second round of PCR was per-
formed using the reverse primer VLJH, located just
upstream of LJH, to amplify the first-round products.
Cycle conditions for the first round were 94C for
5 minutes followed by 30 cycles at 94C for 45 seconds,
50C for 45 seconds, and 72C for 45 seconds and an
additional 10-minute extension at 72C. The same PCR
temperature profile was used for the second round, but
the cycle number was reduced to 20. Heteroduplex analy-
sis was performed by loading 15 lL of PCR product onto
a 4% agarose Tris-acetate-ethylenediamine tetraacetic
acid (TAE) gel immediately after denaturing of the prod-
uct at 94C for 5 minutes and cooling at 4C for
10 minutes. We then tested the DNA quality of the sam-
ples and the inhibition of PCR by amplifying the 5 exon
of the p53 gene as a gene control (as described in the kit).
Denaturing high-performance liquid
chromatography analysis
After heteroduplex induction, the clonality status of
each product was evaluated by denaturing high-perform-
ance liquid chromatography (DHPLC) on a Transge-
nomic WaveTM System Model 3500HT (Transgenomic
Inc, Omaha, Neb) on a high-resolution micropellicular
matrix. Elution profiles were examined at 50C (native
DNA). Ten-lL samples were injected onto a preheated
(50C) C18 reversed-phase column with nonporous poly-
styrene-divinylbenzene particles (DNA Sep; Transge-
nomic). The injected sample was eluted with a linear
acetonitrile gradient consisting of buffer A (0.1 mol/L of
triethylammonium acetate [TEAA]) and buffer B
(0.1 mol/L of TEAA and 250 mL/L of acetonitrile) with a
2% increase of buffer B occurring per minute. PCR prod-
ucts were separated with a flow rate of 0.9 mL/min.
Retention time was measured online via ultraviolet ab-
sorbance at 254 nanometers (nm) in the elute. Resulting
diagrams showed absorbance intensity in millivolts over
the retention time in minutes (mV/min) after injection
onto the column.
Statistical Analysis
Statistical analysis was performed to evaluate possibly sig-
nificant associations between the clinical US presentation
(nodular or diffuse) and the cytologic pattern (lympho-
cytic, lymph node-like, and mixed) using a chi-square test
and, when necessary, a Fisher exact test. Statistical analysis
was also performed to evaluate possible associations
between cytologic patterns (lymphocytic or lymph node-
like) and phenotypic cell type prevalence in the TLI
(T lymphocytes [CD3 positive (þ), CD5þ], B lympho-
cytes [CD19þ], and follicular center cells [CD10þ]).
Because these latter parameters had a non-normal distri-
bution, possible associations were evaluated using a non-
parametric test (Mann-Whitney U test). With regard to
light chain expression, all cases were first classified accord-
ing to the percentage of the expressing cells (20% or
>20%), and the chi-square test was then performed to
evaluate the incidence of unbalanced cases in the 2 groups.
All statistical tests were performed using SPSS software
(SPSS Inc, Chicago, Ill).
RESULTS
Cytologic Patterns
Cytologic smears of HT demonstrated a variable number
of normal follicular cells and Hurthle cells that were
organized mainly in small loose groups, sometimes in fol-
licular structures and sometimes isolated, with numerous
dispersed lymphocytes in the background. The propor-
tion of follicular cells, Hurthle cells, and lymphocytes var-
ied, with a prevalence of 1 component in each case.
Follicular cells were isolated or organized in small groups
or follicular structures (Fig. 2). Nuclei were the same size
as those of the small lymphocytes and even smaller than
those of lymphoid follicular center cells. Therefore, they
were not easily distinguishable from the latter (Fig. 2).
Hurthle cells demonstrated the classically reported fea-
tures,11 being large with wide, grayish, occasionally granu-
lar, well-defined cytoplasm and 1 or 2 slightly eccentric
nuclei (Fig. 1). These cells had variable anisonucleosis and
sometimes quite large, atypical nuclei with dense chroma-
tin and 1 or 2 evident nucleoli were present. The lymph-
oid infiltrate was comprised of a variable number of small
lymphocytes with compact chromatin, plasma cells, mac-
rophages with intermingled lymphocytes, and occasional
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bundles of crushed lymphocyte nuclei, referred to as
‘‘lymphoid tangles’’ (Fig. 1). In some cases, there were also
follicular center cells in different stages of maturation,
ranging from medium to large, and immunoblasts, giving
the smear a lymph node-like appearance (Fig. 2). The
entire series was reviewed by 2 of the authors and each
case was classified, according to the cytologic pattern, as
lymphocytic (12 cases), lymph node-like (14 cases), or
mixed (8 cases) (Table 1).
FC Findings
FC demonstrated 2 main immunophenotypical cell pop-
ulations of CD3þ, CD5þ, and CD19þ lymphocytes,
ranging between 12% and 74% and 8% and 52%, respec-
tively. There was a prevalence of CD3þ, CD5þ (Fig. 3)
in 30 of 34 cases and of CD19þ in 4 of 34 cases (Fig. 3).
CD3þ, CD5þ lymphocytes were present in all cases; in
the absence of a significant number of CD19þ cells,
(<20% of the gated cells), we classified these cases as
being of the T-cell phenotype. Conversely, in 22 cases,
there was a significant presence of CD19þ (20%), and
we determined these cases to be of the B-cell phenotype
(Fig. 4). CD10þ cells were observed in 21 of 34 cases,
and in 14 cases were associated with CD19þ with a vari-
able percentage of coexpression (Fig. 5). In 5 cases,
CD10þ cells represented a separate cluster in the forward
scatter histogram with CD19þ cells identified in another
cluster if present. Light chains were expressed in 30 of
34 cases; in 13 cases, light chains were expressed in<20%
Table 1. Clinical, Cytologic, Flow Cytometry, and PCR Data for 34 Cases of Hashimoto Thyroiditis
Case
No.
Age,
Years/
Gender
US
Pattern
Cytologic
Pattern
CD31,
CD51,
%
CD191,
%
CD101,
%
CD101,
CD191,
%
k1k,
%
j/k PCR
1 28/Woman Nodular Lymph node-like 21 5 40 0 11 4.50 NS
2 54/Woman Diffuse Lymphocytic 54 10 35 0 6 2.00 NP
3 48/Woman Nodular Mixed 16 13 45 0 0 0.00 NP
4 44/Woman Nodular Lymphocytic 60 30 0 0 28 2.50 NP
5 47/Woman Nodular Lymphocytic 66 10 0 0 4 1.00 NP
6 47/Woman Diffuse Lymphocytic 28 10 40 0 0 0.00 NP
7 34/Woman Nodular Mixed 30 18 12 12 23 1.09 NP
8 27/Woman Nodular Lymph node-like 61 24 16 13 24 1.40 NP
9 46/Woman Nodular Mixed 55 37 19 19 28 1.15 NP
10 54/Woman Nodular Lymph node-like 54 35 8 5 35 2.18 NP
11 47/Woman Nodular Lymph node-like 50 32 22 20 21 4.25 Neg
12 41/Woman Nodular Lymphocytic 72 20 0 0 28 1.54 NP
13 56/Woman Diffuse Lymphocytic 74 10 0 0 10 4.00 Neg
14 52/Woman Nodular Mixed 48 21 0 0 28 1.00 NP
15 23/Woman Diffuse Lymphocytic 66 29 20 18 16 1.00 NP
16 50/Woman Nodular Lymphocyte 65 10 0 0 23 1.50 NP
17 51/Woman Nodular Lymph node-like 18 21 11 10 10 1.50 NP
18 54/Woman Nodular Mixed 54 36 0 0 32 1.13 NP
19 29/Woman Nodular Mixed 59 22 19 10 0 0.00 NP
20 46/Woman Nodular Lymphocytic 30 43 20 18 25 3.16 NP
21 54/Woman Nodular Lymph node-like 60 36 6 5 30 1.50 NP
22 55/Woman Diffuse Lymphocytic 67 8 0 0 0 0.00 NP
23 73/Woman Nodular Lymph node-like 20 43 10 10 31 4.16 Neg
24 58/Woman Nodular Lymphocytic 70 20 0 0 7 1.33 NP
25 58/Woman Nodular Lymph node-like 38 30 0 0 11 1.20 NP
26 50/Woman Nodular Lymph node-like 50 30 0 0 27 1.07 NP
27 47/Woman Diffuse Mixed 60 25 5 0 20 1.22 NP
28 42/Woman Nodular Lymph node-like 34 16 0 0 7 1.33 NP
29 25/Woman Nodular Lymphocytic 47 22 0 0 22 1.2 NP
30 46/Woman Nodular Lymph node-like 45 37 25 25 35 1.69 NP
31 34/Woman Nodular Lymph node-like 40 33 12 12 16 3.00 NS
32 55/Woman Nodular Mixed 36 16 10 7 15 1.14 NP
33 38/Woman Nodular Lymph node-like 39 52 17 15 44 1.31 NP
34 38/Woman Nodular Lymph node-like 12 10 50 0 12 5.00 Neg
PCR indicates polymerase chain reaction; US, ultrasound; þ, positive; kþk %, percentage of light chain-producing cells within the whole gate; j/k, light chain
ratio; NS, not sufficient DNA; NP, not performed; Neg, negative for clonality by PCR for immunoglobulin H gene rearrangement.
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of the gated cells and in>20% in 17 cases. With regard to
the j/k ratio, 5 of the 34 cases demonstrated a j/k light
chain ratio of >3.7 (4.0) (Fig. 6); in the remaining
cases, there was a balanced ratio (3.10 and1.00) (Figs.
5 and 6). Finally, when comparing the j/k unbalanced
cases with the quantitative percentage light chain-express-
ing cells, 3 of these cases were found to be low producing
(20%) (Cases 1, 13, and 34) and 2 were found to be
high producing (>20%) (Cases 11 and 23). Clinical,
cytologic, and FC data are summarized in Table 1.
PCR Findings
Heteroduplex analysis of the 2 lymphoma controls and
the positive control supplied with the kit demonstrated
1 or 2 thin clear bands within the expected size range of
240 to 260 base pairs (bp), confirming monoclonality.
Analysis of the 4 thyroiditis cases and the negative control
supplied with the kit resulted in rough smears (strong dif-
fuse bands) in the gel (Fig. 7). After heteroduplex and
homoduplex formation, all samples analyzed demon-
strated the expected band of 274 bp in the p53 gene con-
trol in the gel (data not shown).
DHPLC Analysis
The heteroduplex of the 4 HT cases demonstrated Gaus-
sian curves; no detectable single peaks were observed in
the negative control. In contrast, a clonal PCR product
forming 3 distinct homoduplex peaks was observed in the
2 positive controls as well as in the positive control, pro-
vided by the kit, containing monoclonal IgH gene rear-
rangements (Fig. 8).
Statistical Findings
Statistical analysis demonstrated significant associations
between a diffuse clinical presentation and the lympho-
cytic cytologic pattern and between a nodular clinical
presentation and the lymph node-like cytologic pattern
(P < .005). Statistically significant associations were also
found between the lymphocytic cytologic pattern and
T-cell phenotype and between the lymph node-like cyto-
logic pattern and B-cell phenotype (P< .05). With regard
to light chain expression, a significant association was
observed between light chain restriction and low light
chain expression (P< .005).
FIGURE 3. Flow cytometry of ’’lymphocytic’’ Hashimoto thy-
roiditis. There was predominant CD5 expression in the lower
right quadrant and low expression of CD19 (<20% of the
gate) in the upper right quadrant. PerCP indicates perdin
chlorophyll protein; FITC, fluorescein isothiocyanate.
FIGURE 4. Flow cytometry of ’’lymph node like’’ Hashimoto
thyroiditis. CD5 (lower right quadrant) and CD19 (upper left
quadrant)-positive cells (>20% of the entire gate) are shown.
PerCP indicates perdin chlorophyll protein; FITC, fluorescein
isothiocyanate.
Original Article
180 Cancer Cytopathology June 25, 2009
DISCUSSION
HT is characterized by progressive loss of thyroid follicu-
lar cells and concomitant replacement of the gland by
lymphocytes, with the formation of germinal centers and
fibrosis.1 Apoptosis is generally agreed to be the main
pathogenetic mechanism of follicular cell destruction;
predominantly Th1-mediated immune activity may pro-
mote apoptosis of thyroid follicular cells, leading to thy-
roid cell destruction and HT.23,24 In fact, overexpression
of FAS and FAS-L by follicular cells and cytokine secre-
tion by T lymphocytes induce apoptosis, although a
direct cytotoxic mechanism is almost certainly possible.25
The gland is colonized by B lymphocytes, which partici-
pate in the autoimmune process by inducing the forma-
tion of autoantibodies and forming lymphoid follicles. B
lymphocytes also constitute the basis for the possible
onset of thyroid lymphoma. With regard to the temporal
evaluation of the appearance of these 2 lymphoid cell
populations, it is conceivable that T lymphocytes are the
first to colonize the gland, followed by B lymphocytes
with germinal center formation as the disease becomes
completely established.1,2,26 Therefore, the TLI is respon-
sible for symmetrical or asymmetrical enlargement as
well as for progressive atrophy and reduction in the size
of the gland. The current study focused on the pheno-
typic and quantitative features of the TLI using FC and
compared the TLI with the clinical presentation and
cytologic pattern. We observed significant associations
between clinical symmetrical enlargement and the lym-
phocytic cytologic pattern and between clinical nodular
presentation and the lymph node-like cytologic pattern.
With regard to the phenotypic features of TLI, signifi-
cant associations were found between the lymphocytic
cytologic pattern and CD3þ, CD5þ lymphocyte preva-
lence and between the lymph node-like pattern and
CD19þ and CD10þ/- phenotype; therefore, these
results suggest that the cytologic features of TLI may be
consistent with its phenotype. As reported earlier, it is
not possible to determine a possible temporal conse-
quentiality or to exclude the possible coexistence of dif-
ferent cell types in different areas of the gland; moreover,
follicular cells and Hurthle cells also may contribute to
symmetrical or asymmetrical enlargement. These limita-
tions notwithstanding, the data from the current study
suggest that a lymph node-like infiltrate with the pres-
ence of B lymphocytes with the formation of lymphoid
FIGURE 5. Flow cytometry of ’’lymph node like’’ Hashimoto
thyroiditis. Two clusters of CD19 (upper left quadrant) and
CD19/CD10 coexpression in the upper right quadrant assess-
ing the ‘‘follicular’’ pattern of the B cell. PerCP indicates per-
din chlorophyll protein; PE, phycoerythrin.
FIGURE 6. Flow cytometry of the j/k light chain ratio in a
‘‘microclonal’’ Hashimoto thyroiditis sample. Nearly all of the
cells expressed the j light chain but producing cells were
<20% of the whole cell gate. PE indicates phycoerythrin;
FITC, fluorescein isothiocyanate.
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follicles may contribute to asymmetrical and hence nod-
ular enlargement of the gland.
Light chain evaluation is generally considered to be
important in the phenotypic discrimination between pol-
yclonal and monoclonal lymphoid processes. The normal
range in benign reactive processes is considered to be from
0.5 to 3.0,17 although some reports have cited signifi-
cantly higher j/k ratios in reactive lymph nodes during
various inflammatory processes.21 This phenomenon has
also been described in HT.18 A recent study19 reported a
j/k ratio of >3.7 in 67% of cases studied, without IgH
rearrangement or any evidence of lymphoma noted dur-
ing follow-up. As reported earlier, we also observed a j/k
ratio of>4.0 in 5 of the cases in the current study. In 4 of
these 5 cases, molecular analysis of the IgH locus demon-
strated the absence of rearrangements, showing diffuse
FIGURE 7. Heteroduplex analysis of monoclonal (line 1-5-8) and polyclonal (line 2-3-4-6-7) of immunoglobulin (Ig) H rearrange-
ments obtained by seminested polymerase chain reaction. Lane 1 indicates positive control from the kit; Lanes 2-3-4-6, Hashi-
moto thyroiditis; Lane 5-8, lymphomas; and Lane 7, negative control from the kit. SMIX, DNA molecular weight marker IX; bp,
base pair.
FIGURE 8. Denaturing high-performance liquid chromatography analysis of monoclonal (orange and violet peaks, lymphoma;
light blue peak, positive control) and polyclonal (blue Gaussian curve) products of immunoglobulin (Ig) H rearrangements
obtained by seminested polymerase chain reaction. mV indicates millivolts; HT, Hashimoto thyroiditis.
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bands in PCR analysis and Gaussian curves, instead of
peaks, with DHPLC. Moreover, although follow-up was
not yet extensive at the time of this report, none of our
cases had developed NHL at the time of last follow-up.
These data further confirm the existence of B-cell popula-
tions with light chain restriction in a variable number of
HT cases, although the percentage is quite variable.18,19
In fact, in the studies currently available in the literature,
the percentage ranges from 30% to 67%18,19; this might
be related to different technical procedures. It also has
been observed that if one focuses on the CD10þ cells, the
percentage is higher; in fact, Chen et al19 observed a j/k
ratio of >3.7 in 67% of CD10þ and 10% of CD10-
cases; these data are closer to the results of the current
study. We did not concentrate on the light chain evalua-
tion of CD10þ cells alone because we were interested in
the entire B-cell population; moreover, primary follicular
(CD10þ) lymphomas of the thyroid are quite rare,
whereas MALT and DLBCL are the most frequently
observed histotypes. As reported earlier, in addition to the
j/k ratio, we also evaluated the percentage of the cell pop-
ulation expressing light chains (20% and >20%) and
observed that 13 of 34 cases, including those found to be
unbalanced, were low producing (20%) (P < .005). In
other studies,18,19 this quantitative aspect of light chain
production was not reported, although the same authors
stated that the B cell percentage in the TLI of their ‘‘clo-
nal’’ cases represented a minority of the cell population.19
We would therefore call this phenomenon ‘‘microclonal-
ity,’’ and it may represent an additional criterion for the
differentiation of HT from lymphomatous processes. A
recent study also demonstrated the presence of clonal
bands in 3 of 10 HT cases using PCR to amplify the IgH
gene VDJ region, although these clonal bands could not
be reproduced from other blocks or from deeper sections
of the same block.20 Moreover, none of the corresponding
patients developed malignant lymphoma during follow-
up.20 At the same time, a study performed on a series of
cases with thyroid lymphoma and coexisting thyroiditis
demonstrated sequence similarities between the clonal
bands in HT and the subsequent thyroid lymphoma
within the same histologic samples.12 These data further
support the concept that thyroid lymphoma may evolve
from HT; nonetheless, the presence of ‘‘microclones’’
identified by FC do not appear to be prelymphomatous
conditions or ‘‘lymphomas in situ’’ as described in lymph
nodes.27 In conclusion, the cytologic pattern of the TLI in
HT is quite representative of the clinical presentation and
phenotypic cell type prevalence. With regard to the j/k
ratio, quantitatively small imbalances detected by FC are
not sustained by heavy chain Ig gene (IgH) rearrange-
ments and appear to be a reactive phenomenon rather
than a prelymphomatous condition. Finally, FNAC may
contribute, in a specific clinicocytologic setting, to the dis-
tinction between florid TLI and NHL, although strict fol-
low-up, at least, appears appropriate considering the to
our knowledge limited experiences available.
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